ORALIVA, INC.

DURHAM, NC · Medtech · Private

AI-linked cytomics-on-a-chip platform (C-AIIDE) for point-of-care oral lesion screening and risk stratification

Claim this profile

Follows are private to you and power your alerts

Updated · oraliva.com

Sector
Medtech
Headquarters
DURHAM, NC
Latest Form D
$1.5M, Mar 2025
Total capital
$5M
Federal grants
$3.5M
4 awards · 2025–2026
Rank in peer group#243 of 538
Private capital raised
$1.5M
1 Form D · last Mar 2025
19 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20252026FEDERAL ↑EQUITY ↓Cumulative $5M$1.2M$1.2M$400K$697K1st Form D$1.5M
20252026FEDERAL ↑EQUITY ↓Cumulative $5M$1.2M$1.2M$400K$697K1st Form D$1.5M

Latest events

  • Federal grantHealth and Human S · Phase II · AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care$697K
  • Federal grantHealth and Human S · Phase I · Point of care diagnostic to improve access to gynecological screening in low-resource settings$400K
  • Federal grantNSF · Phase II · STTR Phase II: Portable Single Cell Cytology and Predictive Analysis Platform for the Early Detection of Epithelial Cancers$1.2M
  • Federal grantHealth and Human S · Phase II · AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care$1.2M
  • Private capital raisedForm D · SEC · 1st filing$1.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#243 · top 45%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Anna GrassiniExecutive Officer, DirectorNamed in SEC Form D filings
  • John McDevittDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .